HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity.

Abstract
Memoquin (1) is a lead compound multitargeted against Alzheimer's disease (AD). It is an AChE inhibitor, free-radical scavenger, and inhibitor of amyloid-β (Aβ) aggregation. A new series of 1 derivatives was designed and synthesized by linking its 2,5-diamino-benzoquinone core with motifs that are present in the structure of known amyloid binding agents like curcumin, the benzofuran derivative SKF64346, or the benzothiazole bearing compounds KHG21834 and BTA-1. The weaker AChE inhibitory potencies and the concomitant nearly equipotent anti-amyloid activities of the new compounds with respect to 1 resulted in a more balanced biological profile against both targets. Selected compounds turned out to be effective Aβ aggregation inhibitors in a cell-based assay. By properly combining two or more distinct pharmacological properties in a molecule, we can achieve greater effectiveness compared to single-targeted drugs for investigating AD.
AuthorsMaria Laura Bolognesi, Manuela Bartolini, Andrea Tarozzi, Fabiana Morroni, Federica Lizzi, Andrea Milelli, Anna Minarini, Michela Rosini, Patrizia Hrelia, Vincenza Andrisano, Carlo Melchiorre
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 21 Issue 9 Pg. 2655-8 (May 01 2011) ISSN: 1464-3405 [Electronic] England
PMID21236667 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • Alkanes
  • Amyloid
  • Amyloid beta-Peptides
  • Cholinesterase Inhibitors
  • Enzyme Inhibitors
  • Ethylamines
  • memoquin
Topics
  • Alkanes (chemistry, pharmacology)
  • Alzheimer Disease (drug therapy)
  • Amyloid (antagonists & inhibitors, genetics)
  • Amyloid beta-Peptides (antagonists & inhibitors, genetics)
  • Cells, Cultured
  • Cholinesterase Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Drug Delivery Systems
  • Drug Discovery
  • Enzyme Inhibitors (pharmacology)
  • Ethylamines (chemistry, pharmacology)
  • Humans
  • Inhibitory Concentration 50
  • Molecular Structure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: